Quarterly report pursuant to Section 13 or 15(d)

LICENSE AGREEMENT WITH OYAGEN (Details Narrative)

v3.22.2
LICENSE AGREEMENT WITH OYAGEN (Details Narrative) - USD ($)
3 Months Ended
Apr. 14, 2021
Jun. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Value of shares issued   $ 3,000,000
License Agreement [Member] | OyaGen Inc [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Number of shares issued (in shares) 86,010  
Value of shares issued $ 3,000,000